David C. Man, MD

David C. Man, MD, Director of the Arrhythmia Center, provides Cardiac Electrophysiology Services at Newark Beth Israel Medical Center. Prior to joining NBIMC, Dr. Man was Director of Electrophysiology at Holy Spirit Hospital at Penn State Health in Camp Hill, P.A.

Dr. Man has over 20 years of experience in clinical electrophysiology. His areas of expertise include Complex Ablation Procedures (for Atrial Fibrillation, Ischemic and Idiopathic VT, and SVT), Left Atrial Appendage Occlusion (Watchman and LARIAT), Lead Extraction, and Implantation of Pacer/Defibrillators (including Leadless Pacemakers, Subcutaneous defibrillators, BiVentricular and His/Left Bundle Pacing).

Committed to research and academia, Dr. Man maintains an active role in various clinical investigations including ablation, device, and pharmacologic trials. He is also a participant in an NIH-funded study of Cardiac Resynchronization Therapy vs. Left Bundle Pacing.

Dr. Man received his medical degree from Albert Einstein College of Medicine, completed Residency at Boston City Hospital, and Fellowships in Cardiology and Electrophysiology at the Hospital of the University of Pennsylvania and Philadelphia Heart Institute, respectively. Over his years of practice, Dr. Man has developed a strong Electrophysiology Department with an active Device Clinic and an Atrial Fibrillation Center that became known for its expertise and emphasis on patient education and the utilization of audiovisual aids and video animations to broaden a patient’s understanding of their conditions and procedural options.

Dr. Man brings that same philosophy of care to our Arrhythmia Center at Newark Beth Israel Medical Center. The Arrhythmia Center offers highly specialized cardiac services; focusing not only on how a heart condition can affect longevity, but also on the patient’s quality of life. Staff aim to treat each patient the way they would want themselves or members of their family to be treated.

Conditions:

Atrial Fibrillation; Supraventricular Tachycardia; Ventricular Tachycardia; Ventricular Arrhythmia; Bradycardia (Slow Heart Beat); Fainting; Palpitation; Risk Assessment of Sudden Cardiac Death from conditions such as Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Long QT Syndrome, WPW, Brugada’s, and other Inheritable Genetic Conditions

Procedures:

Complex Ablations; Percutaneous LAA Ligation (Watchman); Pacemakers; Defibrillators; Biventricular Defibrillators; Subcutaneous Defibrillator; Leadless Pacemaker Implantation; Transvenous Extraction of Device Systems

Current Research:

• Principal Investigator at NBI for NIH trial Left vs Left (Cardiac Resynchronization Therapy Using His/Left Bundle
• Branch Pacing vs Biventricular Pacing with a Left Ventricular Epicardial Lead in Patients with Heart Failure (HF) with Left
• Ventricular Ejection Fraction (LVEF) ≤ 50% and with either a Wide QRS Complex (> 130 ms) or with/anticipated > 40% Pacing Randomized Clinical Trial)